[시장보고서]보툴리눔톡신(보톡스) 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 용도별, 최종 용도별, 지역별, 부문별 예측(2026-2033년)

보툴리눔톡신(보톡스) 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 용도별, 최종 용도별, 지역별, 부문별 예측(2026-2033년)

Botulinum Toxin Market Size, Share & Trends Analysis Report By Product (Botulinum Toxin Type A, Botulinum Toxin Type B), By Application (Therapeutic, Aesthetic), By End-use, By Region, And Segment Forecasts, 2026 - 2033

상품코드 : 1941522

리서치사 : Grand View Research

발행일 : 2026년 01월

페이지 정보 : 영문 150 Pages

라이선스 & 가격 (부가세 별도)

US $ 5,950

￦ 8,957,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950

￦ 10,462,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950

￦ 13,473,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

보툴리눔톡신(보톡스) 시장 요약

세계의 보툴리눔톡신(보톡스) 시장 규모는 2025년에 132억 달러로 추정되며, 2033년까지 279억 달러에 달할 것으로 예측됩니다.

2026년부터 2033년까지 CAGR 9.9%의 성장률을 보일 것으로 예상됩니다. 보툴리눔톡신은 보툴리눔균(Clostridium botulinum)이 생산하는 단백질이자 신경독소입니다.

이 독소는 신경에서 분비되는 아세틸콜린의 선택적 차단제로 근육에 주입하면 신경의 신경전달을 차단합니다. 보툴리눔톡신은 의학 및 과학 분야에서 가장 특이한 물질 중 하나입니다. 미용 분야에서 보툴리눔톡신의 사용은 지난 10년간 급속히 확대되어 현재 세계에서 가장 보편적이고 널리 시행되는 미용 시술 중 하나가 되었습니다. 선진국과 개발도상국을 막론하고 미용에 대한 관심이 높아지면서 미용 시술 건수도 증가하는 추세입니다.

보톡스, 제오민, 디스포트 등 다양한 보툴리눔톡신 제제가 출시되어 시장 성장을 가속화할 것입니다. 눈썹 사이 주름 치료, 화학적 눈썹 리프트, 이마 주름 등 여러 미용 시술에서 보툴리눔톡신 주사의 사용 증가는 향후 몇 년 동안 보툴리눔톡신 산업의 성장을 촉진할 것으로 예상됩니다. 현재 시중에는 A형 보툴리눔톡신 제품은 여러 종류가 있으며, B형(마이오블락)은 1개 제품만 시판되고 있습니다.

그러나 주요 제조업체들이 보툴리눔톡신의 치료용도 발굴을 위한 연구개발 프로그램에 대한 투자를 늘리면서 가까운 미래에 치료용 응용 분야를 확대할 수 있는 기회를 창출하고 있습니다. 침습적 수술에서 최소침습적 수술로의 전환은 예측 기간 동안 시장 성장을 촉진할 것으로 예상됩니다. 많은 분들이 필러, 지방이식, 입술전진술 등의 영구적인 시술을 선택하고 있습니다.

최소침습적 시술은 침습적 수술에 비해 절개 부위 축소, 입원 기간 단축, 빠른 외래 진료, 상처 치유 촉진, 통증 감소, 합병증 위험 감소 등의 이점을 제공합니다. 따라서 예측 기간 동안 보툴리눔톡신에 대한 수요가 증가할 것으로 예상됩니다.

영문목차

Botulinum Toxin Market Summary

The global botulinum toxin market size was estimated at USD 13.2 billion in 2025 and is projected to reach USD 27.9 billion by 2033, growing at a CAGR of 9.9% from 2026 to 2033. Botulinum toxin is a protein and neurotoxin produced by the bacterium clostridium botulinum.

The toxin is a selective blocker of acetylcholine released from nerves, which blocks neural transmission from the nerves when injected into muscle. Botulinum toxin is one of the most exceptional substances encountered in medicine and science. The adoption of botulinum toxin in cosmetology has grown rapidly over the past decade, and at present it is one of the most common and widely performed aesthetic procedures in the world. The growing concern for aesthetic features in both developed and developing regions has led to a rise in the number of cosmetic procedures.

The availability of a variety of botulinum toxin products, such as botox, xeomin, dysport, and others, will accelerate the market growth. The increasing usage of botulinum toxin injection in several aesthetic procedures, including the treatment of glabellar lines, chemical browlift, forehead lines, and others, is expected to boost the botulinum toxin industry growth over the coming years. Presently, a few products of botulinum toxin - Type-A and only one product of Type-B (Myobloc) are commercially available in the market.

However, rising investment in R&D programs by major manufacturers to explore the therapeutic use of botulinum toxin is building opportunities for the expansion of its therapeutic application area soon. A shift from invasive to minimally invasive procedures is expected to fuel the market growth over the forecast period. Many people are opting for permanent procedures, such as fillers, fat grafting, and lip advancement.

Minimally invasive procedures offer advantages such as smaller incisions, shorter hospital stays, quick outpatient services, rapid wound healing, less pain, and a lower risk of complications than invasive surgeries. Thus, the demand for botulinum toxin is expected to increase over the forecast period.

Global Botulinum Toxin Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of latest industry trends in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the global botulinum toxin market report on the basis of product, application, end use, and region:

Product Outlook (Revenue, USD Billion, 2021 - 2033)
Type A
- Botox
- Dysport
- Xeomin
- Others
Type B
Application Outlook (Revenue, USD Billion, 2021 - 2033)
Therapeutic
- Chronic Migraine
- Overactive Bladder
- Cervical Dystonia
- Spasticity
- Others
- Aesthetic
Glabellar Lines
- Crow's Feet
- Forehead Lines
- Others
End Use Outlook (Revenue, USD Billion, 2021 - 2033)
Hospitals
Dermatology Clinics
MedSpas and Cosmetic Centers
Regional Outlook (Revenue, USD Billion, 2021 - 2033)
North America
- U.S.
- Canada
- Mexico
Europe
- UK
- Germany
- France
- Italy
- Spain
- Sweden
- Denmark
- Norway
Asia Pacific
- India
- Japan
- China
- South Korea
- Australia
- Thailand
Latin America
- Brazil
- Argentina
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Segment Definitions
- 1.2.1. Product Type
- 1.2.2. Application
- 1.2.3. End Use
- 1.2.4. Regional scope
- 1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
  - 1.4.5.1. Data for primary interviews in North America
  - 1.4.5.2. Data for primary interviews in Europe
  - 1.4.5.3. Data for primary interviews in Asia Pacific
  - 1.4.5.4. Data for primary interviews in Latin America
  - 1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
- 1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.7.3. Volume price analysis (Model 2)
- 1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
- 2.2.1. Product Type outlook
- 2.2.2. Application outlook
- 2.2.3. End Use outlook
- 2.2.4. Regional outlook
2.3. Competitive Insights

Chapter 3. Botulinum Toxin Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
  - 3.2.1.1. Increasing number of patients having neurological disorders
  - 3.2.1.2. Rising preference for non-invasive or minimally invasive procedures
  - 3.2.1.3. Increasing concern regarding aesthetic appearance in 40-54 age group has increased the adoption rate
- 3.2.2. Market Restraint Analysis
  - 3.2.2.1. High cost of cosmetic procedure
3.3. Botulinum Toxin Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
  - 3.3.1.1. Bargaining power of suppliers
  - 3.3.1.2. Bargaining power of buyers
  - 3.3.1.3. Threat of substitutes
  - 3.3.1.4. Threat of new entrants
  - 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
  - 3.3.2.1. Political landscape
  - 3.3.2.2. Economic landscape
  - 3.3.2.3. Social landscape
  - 3.3.2.4. Technological landscape
  - 3.3.2.5. Environmental landscape
  - 3.3.2.6. Legal landscape

Chapter 4. Botulinum Toxin Market: Product Type Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Botulinum Toxin Market: Product Type Movement Analysis
4.3. Botulinum Toxin Market by Product Type Outlook (USD Million)
4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
4.5. Type A
- 4.5.1. Type A Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.5.2. Botox
  - 4.5.2.1. Botox Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.5.3. Dysport
  - 4.5.3.1. Dysport Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.5.4. Xeomin
  - 4.5.4.1. Xeomin Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.5.5. Others
  - 4.5.5.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6. Type B
- 4.6.1. Type B Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Botulinum Toxin Market: Applicatio Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Botulinum Toxin Market: Application Movement Analysis
5.3. Botulinum Toxin Market by Application Outlook (USD Million)
5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
5.5. Therapeutic
- 5.5.1. Therapeutic Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.5.2. Chronic Migraine
  - 5.5.2.1. Chronic Migraine Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.5.3. Overactive Bladder
  - 5.5.3.1. Overactive Bladder Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.5.4. Cervical Dystonia
  - 5.5.4.1. Cervical Dystonia Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.5.5. Spasticity
  - 5.5.5.1. Spasticity Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.5.6. Others
  - 5.5.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6. Aesthetic
- 5.6.1. Aesthetic Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.6.2. Glabellar Lines
  - 5.6.2.1. Glabellar Lines Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.6.3. Crow's Feet
  - 5.6.3.1. Crow's Feet Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.6.4. Forehead Lines
  - 5.6.4.1. Forehead Lines Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.6.5. Others
  - 5.6.5.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Botulinum Toxin Market: End Use Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. Botulinum Toxin Market: End Use Movement Analysis
6.3. Botulinum Toxin Market by End Use Outlook (USD Million)
6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
6.5. Hospitals
- 6.5.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. Dermatology Clinics
- 6.6.1. Dermatology Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7. MedSpas and Cosmetic Centers
- 6.7.1. MedSpas and Cosmetic Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Botulinum Toxin Market: Regional Estimates & Trend Analysis

7.1. Regional Dashboard
7.2. Regional Botulinum Toxin Market Movement Analysis
7.3. Botulinum Toxin Market: Regional Estimates & Trend Analysis by Product Type & End Use
7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
7.5. North America
- 7.5.1. North America Botulinum Toxin Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.2. U.S.
  - 7.5.2.1. U.S. Botulinum Toxin Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.3. Canada
  - 7.5.3.1. Canada Botulinum Toxin Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.4. Mexico
  - 7.5.4.1. Mexico Botulinum Toxin Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.5. Europe
- 7.5.6. Europe Botulinum Toxin Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.7. UK
  - 7.5.7.1. UK Botulinum Toxin Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.8. Germany
  - 7.5.8.1. Germany Botulinum Toxin Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.9. France
  - 7.5.9.1. France Botulinum Toxin Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.10. Italy
  - 7.5.10.1. Italy Botulinum Toxin Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.11. Spain
  - 7.5.11.1. Spain Botulinum Toxin Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.12. Sweden
  - 7.5.12.1. Sweden Botulinum Toxin Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.13. Denmark
  - 7.5.13.1. Denmark Botulinum Toxin Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.14. Norway
  - 7.5.14.1. Norway Botulinum Toxin Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6. Asia Pacific
- 7.6.1. Asia Pacific Botulinum Toxin Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.2. Japan
  - 7.6.2.1. Japan Botulinum Toxin Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.3. China
  - 7.6.3.1. China Botulinum Toxin Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.4. India
  - 7.6.4.1. Key Country Dynamics
  - 7.6.4.2. India Botulinum Toxin Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.5. South Korea
  - 7.6.5.1. South Korea Botulinum Toxin Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.6. Australia
  - 7.6.6.1. Australia Botulinum Toxin Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.7. Thailand
  - 7.6.7.1. Thailand Botulinum Toxin Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.7. Latin America
- 7.7.1. Latin America Botulinum Toxin Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7.2. Brazil
  - 7.7.2.1. Brazil Botulinum Toxin Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7.3. Argentina
  - 7.7.3.1. Argentina Botulinum Toxin Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.8. Middle East & Africa
- 7.8.1. Middle East & Africa Botulinum Toxin Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.8.2. South Africa
  - 7.8.2.1. South Africa Botulinum Toxin Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.8.3. Saudi Arabia
  - 7.8.3.1. Saudi Arabia Botulinum Toxin Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.8.4. UAE
  - 7.8.4.1. UAE Botulinum Toxin Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.8.5. Kuwait
  - 7.8.5.1. Kuwait Botulinum Toxin Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

8.1. Market Participant Categorization
8.2. Key Company Profiles
- 8.2.1. Ipsen Group
  - 8.2.1.1. Company Overview
  - 8.2.1.2. Financial Performance
  - 8.2.1.3. Product Benchmarking
  - 8.2.1.4. Strategic Initiatives
- 8.2.2. Allergan, Inc.
  - 8.2.2.1. Company Overview
  - 8.2.2.2. Financial Performance
  - 8.2.2.3. Product Benchmarking
  - 8.2.2.4. Strategic Initiatives
- 8.2.3. Metabiologics
  - 8.2.3.1. Company Overview
  - 8.2.3.2. Financial Performance
  - 8.2.3.3. Product Benchmarking
  - 8.2.3.4. Strategic Initiatives
- 8.2.4. Merz Pharma
  - 8.2.4.1. Company Overview
  - 8.2.4.2. Financial Performance
  - 8.2.4.3. Product Benchmarking
  - 8.2.4.4. Strategic Initiatives
- 8.2.5. US Worldmeds
  - 8.2.5.1. Company Overview
  - 8.2.5.2. Financial Performance
  - 8.2.5.3. Product Benchmarking
  - 8.2.5.4. Strategic Initiatives
- 8.2.6. Evolus
  - 8.2.6.1. Company Overview
  - 8.2.6.2. Financial Performance
  - 8.2.6.3. Product Benchmarking
  - 8.2.6.4. Strategic Initiatives
- 8.2.7. Galderma
  - 8.2.7.1. Company Overview
  - 8.2.7.2. Financial Performance
  - 8.2.7.3. Product Benchmarking
  - 8.2.7.4. Strategic Initiatives
- 8.2.8. Medy-Tox, Inc.
  - 8.2.8.1. Company Overview
  - 8.2.8.2. Financial Performance
  - 8.2.8.3. Product Benchmarking
  - 8.2.8.4. Strategic Initiatives
- 8.2.9. Lanzhou Institute of Biological Products
  - 8.2.9.1. Company Overview
  - 8.2.9.2. Financial Performance
  - 8.2.9.3. Product Benchmarking
  - 8.2.9.4. Strategic Initiatives

한글목차

보툴리눔톡신(보톡스) 시장 요약

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 보툴리눔톡신(보톡스) 시장 변수, 동향 및 범위

제4장 보툴리눔톡신(보톡스) 시장 : 제품 유형별 추정·동향 분석

제5장 보툴리눔톡신(보톡스) 시장 : 용도별 추정·동향 분석

제6장 보툴리눔톡신(보톡스) 시장 : 최종 용도별 추정·동향 분석

제7장 보툴리눔톡신(보톡스) 시장 : 지역별 추정·동향 분석

제8장 경쟁 구도